Access our latest resources—including publications about our science, recent media, and conference presentations.

Mar 2023 | From Ikena Oncology

The Ah Receptor from Toxicity to Therapeutics. Report from the 5th AHR Meeting at Penn State University, USA, June 2022

McGovern, K et al. | International Journal of Molecular Sciences

Oct 2022 | From Ikena Oncology

IK-930, a Novel TEAD-inhibitor, Overcomes Hippo/YAP-mediated Adaptive Response to MEK and EGFR-targeted Therapies

Mihir Rajurkar, Ph.D. | EORTC-NCI-AACR 2022

Scroll to Top